Conference
NCIC-CTG MA14 Trial: Tamoxifen (tam) vs. tam plus octreotide (oct) for adjuvant treatment of stage I or II postmenopausal breast cancer
Authors
Pollak MN; Chapman JW; Pritchard KI; Krook JE; Dhaliwal HS; Vandenberg TA; Norris BD; Whelan TJ; Wilson CF; Shepherd LE
Volume
26
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2008
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X